|
2022 Book Chapter Relaxin/serelaxin for cardiac dysfunction and heart failure in hypertensionChunduri, Prasad, Patel, Shrey A. and Levick, Scott P. (2022). Relaxin/serelaxin for cardiac dysfunction and heart failure in hypertension. New targets for the treatment of hypertension and associated diseases. (pp. 183-211) edited by William B. Campbell and John D. Imig. Cambridge, MA, United States: Academic Press. doi: 10.1016/bs.apha.2022.04.002 |
